UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000044639
Receipt No. R000050973
Scientific Title Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain in Japan
Date of disclosure of the study information 2021/08/01
Last modified on 2021/06/24 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain in Japan
Acronym epidemiological survey of ASD and ADHD with chronic pain in Japan
Scientific Title Prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain in Japan
Scientific Title:Acronym epidemiological survey of ASD and ADHD with chronic pain in Japan
Region
Japan

Condition
Condition autism spectrum disorder, attention-deficit hyperactivity disorder
Classification by specialty
Psychiatry
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 investigation autism spectrum disorder and atention-deficit hyperactivity disorder in adult with chronic pain in Japan
Basic objectives2 Others
Basic objectives -Others investigation of prevalence, location, duration and causes of chronic pan in ASD and ADHD in adult in Japan
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes prevalence of prevalence of autism spectrum disorder and attention-deficit hyperactivity disorder in adults with chronic pain
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with ASD and ADHD over 20 years old
Key exclusion criteria dementia
patients who cannot read and write Japanese
Target sample size 250

Research contact person
Name of lead principal investigator
1st name YOSUKE
Middle name
Last name TOMINAGA
Organization Showa university Karasuyama hospital
Division name Psychiatry
Zip code 157-8577
Address 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo
TEL 03-3300-5231
Email ytomi@med.showa-u.ac.jp

Public contact
Name of contact person
1st name YOSUKE
Middle name
Last name TOMINAGA
Organization Showa university Karasuyama hospital
Division name Psychiatry
Zip code 157-8577
Address 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo
TEL 03-3300-5231
Homepage URL
Email ytomi@med.showa-u.ac.jp

Sponsor
Institute Showa university
Institute
Department

Funding Source
Organization Showa university
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Review Board of ShowaUniversity Karasuyama Hospital
Address 6-11-11 Kitakarasuyama, Setagaya-ku, Tokyo
Tel 0333005231
Email scri@ofc.showa-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2021 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2021 Year 06 Month 24 Day
Date of IRB
Anticipated trial start date
2021 Year 08 Month 01 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information epidemiological study, prevalence study

Management information
Registered date
2021 Year 06 Month 24 Day
Last modified on
2021 Year 06 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050973